New derivatives of 6-nitrocoumarin-3-thiosemicarbazone exhibit improved antiparasitic activity in the placenta against Trypanosoma cruzi and Toxoplasma gondii
Antimicrobial Agents and Chemotherapy · 2025
DOI: 10.1128/aac.00454-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Esteban Rocha-Valderrama und 11 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Universitario de Investigación y Desarrollo Tecnológico, Universidad Tecnológica Metropolitana, Santiago, Chile. Hauptthemen laut MEDLINE: Toxoplasma, Trypanosoma cruzi, Thiosemicarbazones, Placenta. Die Arbeit nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pontificia Universidad Católica del Ecuador, Agencia Nacional de Investigacion y Desarrollo, ANID, Competition for Research Regular Projects.
Abstract (Originalsprache)
Congenital infections by Trypanosoma cruzi and Toxoplasma gondii pose significant clinical challenges due to the lack of safe and effective treatments. This study evaluates eight novel 6-nitrocoumarin-3-thiosemicarbazone derivatives in an ex vivo human placenta model, assessing their antiparasitic activity and impact on tissue integrity. Two therapeutic approaches were tested: pre-infection (preventive) and post-infection (therapeutic). In vitro and ex vivo assays revealed strong activity trends. Compound 7 was the most effective against T. cruzi (IC 50 = 22.4 ± 0.8 µM, logP = 2.49), while compound 1 exhibited the highest activity against T. gondii (IC 50 = 17.3 ± 0.5 µM, logP = 1.44). Unlike current treatments, none of the compounds induced placental tissue damage, preserving trophoblast function. Structure-activity relationship (SAR) analysis identified an inverse correlation between lipophilicity and antiparasitic activity in T. gondii , where polar compounds were more effective. In T. cruzi , higher lipophilicity favored trypanocidal activity, suggesting differential cell permeability mechanisms. Mechanistic studies using electrochemistry and electron spin resonance (ESR) demonstrated that nitro group bioreduction promotes ROS generation, explaining activity against T. cruzi . By contrast, lower ROS levels in T. gondii suggest alternative mechanisms. This study validates the ex vivo human placenta model as a clinically relevant platform for antiparasitic drug screening. The findings highlight 6-nitrocoumarin-3-thiosemicarbazones as promising early-stage candidates that warrant further optimization to develop safer and more effective therapies for congenital infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Universitario de Investigación y Desarrollo Tecnológico, Universidad Tecnológica Metropolitana, Santiago, Chile.
- Inorganic and Analytical Department, Free Radical and Antioxidants Laboratory, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.
- Área Química Inorgánica, DEC, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
- Graduate Program in Chemistry, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
- Programa de Biología Integrativa, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago, Chile.
- Departamento de Química Orgánica, Laboratorio de Química Farmacéutica, Facultad de Química, Universidad de la República, Montevideo, Uruguay.
ORCID-Profile: Jaime A Costales, Lucía Otero, Mauricio Moncada-Basualto
Förderung
- Pontificia Universidad Católica del Ecuador
- Agencia Nacional de Investigacion y Desarrollo, ANID
- Competition for Research Regular Projects
Zitieren
APA
Rocha-Valderrama, E., Rostán, S., Fernández, M., Liempi, A., Castillo, C., Mahler, G., Galarza-Jarrin, A., Costales, J. A., Pozo-Martínez, J., Olea-Azar, C., Otero, L., & Moncada-Basualto, M. (2025). New derivatives of 6-nitrocoumarin-3-thiosemicarbazone exhibit improved antiparasitic activity in the placenta against Trypanosoma cruzi and Toxoplasma gondii. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00454-25
Vancouver
Rocha-Valderrama E, Rostán S, Fernández M, Liempi A, Castillo C, Mahler G, et al. New derivatives of 6-nitrocoumarin-3-thiosemicarbazone exhibit improved antiparasitic activity in the placenta against Trypanosoma cruzi and Toxoplasma gondii. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00454-25
BibTeX
@article{RochaValderrama2025,
author = {Rocha-Valderrama, Esteban and Rostán, Santiago and Fernández, Mercedes and Liempi, Ana and Castillo, Christian and Mahler, Graciela and Galarza-Jarrin, Ambar and Costales, Jaime A and Pozo-Martínez, Josué and Olea-Azar, Claudio and Otero, Lucía and Moncada-Basualto, Mauricio},
title = {New derivatives of 6-nitrocoumarin-3-thiosemicarbazone exhibit improved antiparasitic activity in the placenta against Trypanosoma cruzi and Toxoplasma gondii},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
doi = {10.1128/aac.00454-25}
}
EUVIMED